Shuxun Wang; Wei Ding; Shenning Lu; Linjia Li; Furong Qian; Canhui Chen; Longsheng Liu; Yongtong Cai; Xian Liu; Sandra Perez; Roger Frutos; Hangping Yao; Yuhang Zhou; Chunsheng Ye; Danna Wu; Shizhu Li; Xiaoxiao Jiang Kwete; Yuan Sui; Duoquan Wang; Shuxun Wang; Wei Ding; Shenning Lu; Linjia Li; Furong Qian; Canhui Chen; Longsheng Liu; Yongtong Cai; Xian Liu; Sandra Perez; Roger Frutos; Hangping Yao; Yuhang Zhou; Chunsheng Ye; Danna Wu; Shizhu Li; Xiaoxiao Jiang Kwete; Yuan Sui; Duoquan Wang

doi:10.46234/ccdcw2025.105

[1]

World Health Organization. World malaria report 2023. Geneva: World Health Organization. 2023. https://www.who.int/publications/i/item/9789240086173. [2025-3-12].

[2]

Yalley AK, Ocran J, Cobbinah JE, Obodai E, Yankson IK, Kafintu-Kwashie AA, et al. Advances in malaria diagnostic methods in resource-limited settings: a systematic review. Trop Med Infect Dis 2024;9(9):190. https://doi.org/10.3390/tropicalmed9090190.

[3]

Mumtaz H, Nadeem A, Bilal W, Ansar F, Saleem S, Khan QA, et al. Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: a review. Immun Inflamm Dis 2023;11(6):e899. https://doi.org/10.1002/iid3.899.

[4]

Naidoo K, Oliver SV. Gene drives: an alternative approach to malaria control? Gene Ther 2025;32(1):25-37. http://dx.doi.org/10.1038/s41434-024-00468-8.

[5]

El-Moamly AA, El-Sweify MA. Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects. Trop Med Health 2023;51(1):29. https://doi.org/10.1186/s41182-023-00516-w.

[6]

Mukkala AN, Kwan J, Lau R, Harris D, Kain D, Boggild AK. An update on malaria rapid diagnostic tests. Curr Infect Dis Rep 2018;20(12):49. https://doi.org/10.1007/s11908-018-0655-4.

[7]

WHO. Malaria threats map. 2025. https://apps.who.int/malaria/maps/threats/. [2025-3-12].

[8]

Obeagu EI, Obeagu GU. Emerging public health strategies in malaria control: innovations and implications. Ann Med Surg 2024;86(11):6576 − 84. https://doi.org/10.1097/ms9.0000000000002578.

[9]

Chen JH, Fen J, Zhou XN. From 30 million to zero malaria cases in China: lessons learned for China–Africa collaboration in malaria elimination. Infect Dis Poverty 2021;10(1):51. https://doi.org/10.1186/s40249-021-00839-y.

[10]

Feng XY, Huang F, Yin JH, Wang RB, Xia ZG. Key takeaways from China’s success in eliminating malaria: leveraging existing evidence for a malaria-free world. BMJ Glob Health 2022;7(4):e008351. https://doi.org/10.1136/bmjgh-2021-008351.

[11]

WHO. From 30 million cases to zero: China is certified malaria-free by WHO. Geneva: World Health Organization. 2021. https://www.who.int/news/item/30-06-2021-from-30-million-cases-to-zero-china-is-certified-malaria-free-by-who. [2025-3-12].

[12]

Li XH, Tu YY, Tang LH, Gao Q, Alonso PL. The role of research in China’s successful elimination of malaria. Nat Med 2022;28(7):1336 − 8. https://doi.org/10.1038/s41591-022-01824-0.

[13]

Tu YY. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17(10):1217 − 20. https://doi.org/10.1038/nm.2471.

[14]

Su XZ, Miller LH. The discovery of artemisinin and the Nobel prize in physiology or medicine. Sci China Life Sci 2015;58(11):1175 − 9. https://doi.org/10.1007/s11427-015-4948-7.

[15]

Feng XY, Feng J, Zhang L, Tu H, Xia ZG. Vector control in China, from malaria endemic to elimination and challenges ahead. Infect Dis Poverty 2022;11(1):54. https://doi.org/10.1186/s40249-022-00971-3.

[16]

Zheng XY, Zhang DJ, Li YJ, Yang C, Wu Y, Liang X, et al. Incompatible and sterile insect techniques combined eliminate mosquitoes. Nature 2019;572(7767):56 − 61. https://doi.org/10.1038/s41586-019-1407-9.

[17]

Zheng JT, Pan H, Gu YN, Zuo X, Ran N, Yuan YZ, et al. Prospects for malaria vaccines: pre‐erythrocytic stages, blood stages, and transmission‐blocking stages. Biomed Res Int 2019;2019:9751471. https://doi.org/10.1155/2019/9751471.

[18]

Rabinovich RN, Drakeley C, Djimde AA, Hall BF, Hay SI, Hemingway J, et al. malERA: an updated research agenda for malaria elimination and eradication. PLoS Med 2017;14(11):e1002456. https://doi.org/10.1371/journal.pmed.1002456.

[19]

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and Explanation. Ann Intern Med 2018;169(7):467 − 73. https://doi.org/10.7326/M18-0850.

[20]

Chibi M, Wasswa W, Ngongoni C, Baba E, Kalu A. Leveraging innovation technologies to respond to malaria: a systematized literature review of emerging technologies. Malar J 2023;22(1):40. https://doi.org/10.1186/s12936-023-04454-0.

[21]

Barker TH, Habibi N, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth 2024;22(3):378 − 88. https://doi.org/10.11124/jbies-23-00268.

[22]

Campbell JM, Klugar M, Ding S, Carmody DP, Hakonsen SJ, Jadotte YT, et al. Diagnostic test accuracy systematic reviews. In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis. JBI. 2020. http://dx.doi.org/10.46658/JBIMES-20-10. [2024-12-24].

[23]

Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, et al. Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI reviewer’s manual. JBI. 2020. http://dx.doi.org/10.46658/JBIRM-17-06. [2024-12-24].

[24]

Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 2020;18(10):2119 − 26. https://doi.org/10.11124/jbies-20-00167.

[25]

Rosenthal PJ, Asua V, Conrad MD. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nat Rev Microbiol 2024;22(6):373 − 84. https://doi.org/10.1038/s41579-024-01008-2.

[26]

Coleman M, Hemingway J, Gleave KA, Wiebe A, Gething PW, Moyes CL. Developing global maps of insecticide resistance risk to improve vector control. Malar J 2017;16(1):86. https://doi.org/10.1186/s12936-017-1733-z.

[27]

Hemingway J, Ranson H, Magill A, Kolaczinski J, Fornadel C, Gimnig J, et al. Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet 2016;387(10029):1785-8. http://dx.doi.org/10.1016/s0140-6736(15)00417-1.

[28]

Suh PF, Elanga-Ndille E, Tchouakui M, Sandeu MM, Tagne D, Wondji C, et al. Impact of insecticide resistance on malaria vector competence: a literature review. Malar J 2023;22(1):19. https://doi.org/10.1186/s12936-023-04444-2.

[29]

Andrade MV, Noronha K, Diniz BPC, Guedes G, Carvalho LR, Silva VA, et al. The economic burden of malaria: a systematic review. Malar J 2022;21(1):283. https://doi.org/10.1186/s12936-022-04303-6.

[30]

Naing C, Htet NH, Aye SN, Aung HH, Tanner M, Whittaker MA. Detection of asymptomatic malaria in Asian countries: a meta-analysis of diagnostic accuracy. Malar J 2022;21(1):50. https://doi.org/10.1186/s12936-022-04082-0.

[31]

He Q, Wang WX, Zhu L. Larvicidal activity of Zanthoxylum acanthopodium essential oil against the malaria mosquitoes, Anopheles anthropophagus and Anopheles sinensis. Malar J 2018;17(1):194. https://doi.org/10.1186/s12936-018-2341-2.

[32]

Susanna D, Pratiwi D. Current status of insecticide resistance in malaria vectors in the Asian countries: a systematic review. F1000Res 2021;10:200. http://dx.doi.org/10.12688/f1000research.46883.2.

[33]

Yang YX, Gao HL, Zhou S, Kuang X, Wang ZJ, Liu HZ, et al. Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment. Drug Deliv Transl Res 2018;8(5):1171 − 9. https://doi.org/10.1007/s13346-018-0537-1.

[34]

Wang DQ, Lv S, Ding W, Lu SN, Zhang HW, Kassegne K, et al. Could China’s journey of malaria elimination extend to Africa? Infect Dis Poverty 2022;11(1):55. http://dx.doi.org/10.1186/s40249-022-00978-w.

[35]

Tine R, Herrera S, Badji MA, Daniels K, Ndiaye P, Smith Gueye C, et al. Defining operational research priorities to improve malaria control and elimination in sub-Saharan Africa: results from a country-driven research prioritization setting process. Malar J 2023;22(1):219. https://doi.org/10.1186/s12936-023-04654-8.

[36]

Achan J, Barry A, Leroy D, Kamara G, Duparc S, Kaszubska W, et al. Defining the next generation of severe malaria treatment: a target product profile. Malar J 2024;23(1):174. https://doi.org/10.1186/s12936-024-04986-z.

[37]

Wittenauer R, Nowak S, Luter N. Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data. Malar J 2022;21(1):12. https://doi.org/10.1186/s12936-021-04008-2.

[38]

Lindblade KA, Hong LX, Tiffany A, Galappaththy G, Alonso P, The WHO E-2020 Team. Supporting countries to achieve their malaria elimination goals: the WHO E-2020 initiative. Malar J 2021;20(1):481. https://doi.org/10.1186/s12936-021-03998-3.

[39]

Ma XJ, Ding W, Qian YJ, Lu SN, Wang B, Xu QL, et al. Deployment of workforce in global health: what should be the priorities for China? Glob Health Res Policy 2021;6(1):22. http://dx.doi.org/10.1186/s41256-021-00208-0.

[40]

Ding W, Guan YY, Peterhans B, Hoffmann A, Zhou XN. Adaptation of the CUGH global health competency framework in the Chinese context: a mixed-methods study. Glob Health Res Policy 2023;8(1):46. https://doi.org/10.1186/s41256-023-00327-w.